BSE Live
Apr 22, 09:33Prev. Close
18.84
Open Price
0.00
Bid Price (Qty.)
18.93 (52)
Offer Price (Qty.)
22.59 (199)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of Nexus Surgical and Medicare Limited (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.91 | 0.39 | 0.31 | 0.53 | 0.28 | |
| Diluted EPS (Rs.) | 0.91 | 0.39 | 0.31 | 0.53 | 0.28 | |
| Cash EPS (Rs.) | 0.92 | 0.39 | 0.31 | 0.54 | 0.29 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 1.94 | 1.03 | 0.65 | 0.33 | -0.20 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 1.94 | 1.03 | 0.65 | 0.33 | -0.20 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 10.46 | 6.35 | 2.84 | 4.38 | 6.84 | |
| PBDIT/Share (Rs.) | 1.23 | 0.53 | 0.42 | 0.71 | 0.32 | |
| PBIT/Share (Rs.) | 1.22 | 0.53 | 0.42 | 0.71 | 0.31 | |
| PBT/Share (Rs.) | 1.22 | 0.53 | 0.42 | 0.71 | 0.31 | |
| Net Profit/Share (Rs.) | 0.91 | 0.39 | 0.31 | 0.53 | 0.28 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 11.74 | 8.42 | 14.81 | 16.31 | 4.62 | |
| PBIT Margin (%) | 11.67 | 8.36 | 14.73 | 16.20 | 4.55 | |
| PBT Margin (%) | 11.67 | 8.36 | 14.73 | 16.20 | 4.55 | |
| Net Profit Margin (%) | 8.69 | 6.13 | 10.99 | 12.11 | 4.11 | |
| Return on Networth / Equity (%) | 46.76 | 37.67 | 48.36 | 159.24 | -142.64 | |
| Return on Capital Employed (%) | 62.79 | 51.33 | 64.82 | 212.97 | -157.83 | |
| Return on Assets (%) | 21.86 | 11.80 | 18.64 | 14.48 | 16.47 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 2.80 | 2.55 | 1.06 | 1.63 | 400.45 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.85 | 1.41 | 1.57 | 0.99 | 0.78 | |
| Quick Ratio (X) | 1.50 | 1.09 | 1.44 | 0.75 | 0.78 | |
| Inventory Turnover Ratio (X) | 13.76 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 8.69 | 7.14 | 4.08 | 4.02 | 1.67 | |
| EV/Net Operating Revenue (X) | 1.52 | 2.06 | 2.63 | 1.68 | 0.45 | |
| EV/EBITDA (X) | 12.94 | 24.41 | 17.73 | 10.28 | 9.64 | |
| MarketCap/Net Operating Revenue (X) | 1.58 | 2.12 | 3.05 | 1.72 | 0.50 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 8.49 | 13.04 | 13.41 | 22.64 | -17.51 | |
| Price/Net Operating Revenue | 1.58 | 2.12 | 3.05 | 1.72 | 0.50 | |
| Earnings Yield | 0.06 | 0.03 | 0.04 | 0.07 | 0.08 |
27.11.2025
Nexus Surgical Standalone September 2025 Net Sales at Rs 1.17 crore, up 17.18% Y-o-Y
13.06.2025
Nexus Surgical Standalone March 2025 Net Sales at Rs 1.48 crore, up 147.81% Y-o-Y
22.01.2025
Nexus Surgical Standalone December 2024 Net Sales at Rs 1.48 crore, up 2.62% Y-o-Y
25.11.2024
Nexus Surgical Standalone September 2024 Net Sales at Rs 0.99 crore, up 169.26% Y-o-Y
27.11.2025
Nexus Surgical Standalone September 2025 Net Sales at Rs 1.17 crore, up 17.18% Y-o-Y
13.06.2025
Nexus Surgical Standalone March 2025 Net Sales at Rs 1.48 crore, up 147.81% Y-o-Y
22.01.2025
Nexus Surgical Standalone December 2024 Net Sales at Rs 1.48 crore, up 2.62% Y-o-Y
25.11.2024
Nexus Surgical Standalone September 2024 Net Sales at Rs 0.99 crore, up 169.26% Y-o-Y
24.06.2024
19.06.2024
HCLTech partners with Tecnotree to develop 5G-led GenAI solutions for telcos
18.06.2024
18.06.2024
Wipro surges over 3% on extended partnership with Hanesbrands, new GBST collaboration
23.04.2024
23.04.2024
Tata Elxsi Q4 net profit, revenue decline QoQ; firm declares dividend of Rs 70 per share
19.04.2024
19.04.2024
Wipro Q4 results: Net profit falls 8% to Rs 2,835 crore, beats estimates
26.02.2024
A for artificial intelligence, B for base effect: The A-Z of Q3 earnings season
02.02.2024
Q3 earnings review: Energy, infra firms lead profit surge; IT, FMCG face headwinds
10.01.2024
Selling pressure in IT stocks ahead of Infy, TCS results; here’s how traders position the market
20.10.2023
Q2 Earnings Review: The bigger they are, the harder they stall?